iShares Neuroscience and Healthcare ETF is a ETF series of iShares Trust (series S000076483). Net assets $5.2M as of 2026-04-30. Index fund.
Showing 15 of 84 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | — | $444K | 857.13% |
| Xenon Pharmaceuticals Inc | — | $248K | 478.59% |
| AXSOME THERAPEUTICS, INC. | — | $238K | 459.31% |
| ARROWHEAD PHARMACEUTICALS, INC. | — | $228K | 440.65% |
| ALKERMES PUBLIC LIMITED COMPANY | — | $217K | 419.94% |
| CENTESSA PHARMACEUTICALS PLC | — | $204K | 395.08% |
| argenx SE | — | $201K | 388.26% |
| PTC THERAPEUTICS, INC. | — | $191K | 369.41% |
| NEUROCRINE BIOSCIENCES, INC. | — | $191K | 368.47% |
| BIOGEN INC. | — | $190K | 367.27% |
| Scholar Rock Holding Corp | — | $190K | 367.07% |
| Praxis Precision Medicines Inc | — | $189K | 366.00% |
| ACADIA PHARMACEUTICALS INC. | — | $187K | 361.33% |
| Dianthus Therapeutics Inc | — | $175K | 339.02% |
| CATALYST PHARMACEUTICALS, INC. | — | $170K | 328.79% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $5.2M |
| 2026-01-31 | $4.9M |
| 2025-10-31 | $4.5M |
| 2025-07-31 | $3.5M |
| 2025-04-30 | $3.4M |
| 2025-01-31 | $3.9M |
| 2024-10-31 | $4.0M |
| 2024-07-31 | $3.9M |